Please enable Javascript on your browser for a better experience.
The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.
The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.
The Cardio IQ™ Apolipoprotein A1 Test measures ApoA1, the main protein in HDL cholesterol. Higher ApoA1 levels are generally linked to lower cardiovascular risk. This test helps evaluate heart health, lipid metabolism, and supports assessment of cardiovascular disease risk.